Iconovo expands deal with Amneal for generic Symbicort, launches pharma division

Iconovo amended its development deal with Amneal for a generic version of Symbicort to add US and Chinese marketing rights for Amneal and Nordic region marketing rights for Iconovo, more than doubling potential future royalty income. Iconovo also launched a new pharma division, Iconovo Pharma.

“We are very pleased to have been able to expand our agreement with Amneal.”oindpnews.com

• 1 source
• oindpnews.comIconovo announces expansion of deal with Amneal on generic Symbicort and launch of pharma division – OINDPnewsMay 1, 2021

Summarized from public sources; check the original articles before acting on it.